Clinical trial
Tolerability, Safety and Pharmacokinetics of a Single Dose of Staccato™ Prochlorperazine for Inhalation in Normal, Healthy Volunteers
NCT00610727 is registered in ClinicalTrials.gov with Nova Pneuma Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tolerability, Safety and Pharmacokinetics of a Single Dose of Staccato™ Prochlorperazine for Inhalation in Normal, Healthy Volunteers
- Lead sponsor
- Nova Pneuma Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 2004
- Completion date
- October 31, 2004
- Enrollment
- 54 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
migraine